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 Introduction 
 Essential tremor (ET), a progressive neurological dis-
ease, is regarded as one of the most prevalent neurological 
disorders  [1–4] . Yet there are wide disparities in preva-
lence estimates, with an approximately 3,000-fold differ-
ence between the lowest and highest estimates  [5] , so that 
prevalence has not been established with precision. A ma-
jor methodological problem is that, with few exceptions 
 [1, 6, 7] , the more than 20 prevalence studies have relied 
on screening questionnaires, which generally have low 
sensitivity.
 Age is a well-established risk factor for ET  [8, 9] , yet 
little is known about other key disease determinants. For 
example, there are few direct comparisons between per-
sons of different ethnicity  [10–12] , so that the role of eth-
nicity as a disease determinant has not been examined in 
detail. Even with regard to age, with a rare exception  [6] , 
studies have not reported data on prevalence among per-
sons aged 90 and older, so that it is not clear whether 
prevalence continues to rise or declines towards the end 
of the age spectrum.
 We assessed the prevalence of ET in a large commu-
nity-based health survey of persons 65 years and older 
(range = 65–102 years) living in northern Manhattan, 
New York, N.Y., USA. We assessed participants indepen-
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 Abstract 
 Background: Our aims were to: (1) estimate the prevalence 
of essential tremor (ET) in a community-based study in 
northern Manhattan, New York, N.Y., USA; (2) compare prev-
alence across ethnic groups, and (3) provide prevalence es-
timates for the oldest old.  Methods: This study did not rely 
on a screening questionnaire. Rather, as part of an in-person 
neurological evaluation, each participant produced several 
handwriting samples, from which ET diagnoses were as-
signed.  Results: There were 1,965 participants (76.7  8 6.9 
years, range = 66–102 years); 108 had ET [5.5%, 95% confi-
dence interval (CI) = 4.5–6.5%]. Odds of ET were robustly as-
sociated with Hispanic ethnicity versus white ethnicity [odds 
ratio (OR) = 2.19, 95% CI = 1.03–4.64, p = 0.04] and age (OR = 
1.14, 95% CI = 1.03–1.26, p = 0.01), i.e. with every 1 year ad-
vance in age, the odds of ET increased by 14%. Prevalence 
reached 21.7% among the oldest old (age  6 95 years).  Con-
clusions: This study reports a significant ethnic difference in 
the prevalence of ET. The prevalence of ET was high overall 
(5.5%) and rose markedly with age so that in the oldest old, 
more than 1 in 5 individuals had this disease. 
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dent of screening results in order to obtain a more com-
plete estimate of ET prevalence. The multiethnic nature 
of this sample further allowed direct comparisons of ET 
prevalence across these ethnic groups.
 Methods 
 Study Sample 
 2,776 individuals participated in a prospective study of aging 
and dementia in Medicare-eligible northern Manhattan resi-
dents, age  6 65 years (Washington/Hamilton Heights-Inwood 
Columbia Aging Project, WHICAP II). The WHICAP II cohort 
represents a combination of continuing members of a cohort 
originally recruited in 1992 (WHICAP I; n = 602) and members 
of a new cohort recruited between 1999 and 2001 (n = 2,174). The 
sampling strategies have been described in detail  [13] . Prevalence 
was previously estimated in a larger sample of members recruit-
ed in 1992  [10] ; therefore, the current analyses were restricted to 
the baseline assessment of the new cohort recruited between 
1999 and 2001 (n = 2,174). Informed consent and study proce-
dures were approved by the Columbia University Institutional 
Review Board.
 In Person Evaluation 
 A trained research assistant collected demographic informa-
tion (including self-reported race, which was coded as non-His-
panic white, Hispanic, non-Hispanic African-American, and 
other) and administered a structured interview of health, which 
included questions on current and past medical conditions and 
current medication use. The structured interview also included 
the questions ‘do your arms or legs shake?’, ‘have you ever been 
told that you have Parkinson’s disease?’, and ‘have you ever taken 
levodopa or Sinemet?’ Names and dosages of all current medica-
tions were collected.
 Each participant also underwent a standardized neurological 
examination by a general physician. The physician was not asked 
to comment on or rate action tremor but performed an abbrevi-
ated (10-item) version of the motor portion of the Unified Parkin-
son’s Disease Rating Scale (UPDRS)  [14] , and assigned a prelimi-
nary diagnosis of Parkinson’s disease (PD) based on the presence 
of 2 or more cardinal signs. Using the same criteria, PD diagnoses 
were then confirmed by a study neurologist based on a second, 
more detailed neurological examination.
 As noted above, examining physicians were not asked to rate 
action tremor. Hence, ET diagnoses were assigned at a later point 
based on handwriting samples. As part of his or her evaluation, 
each participant was asked to generate 2 handwriting samples. 
The first set of handwriting samples was administered as part of 
a neuropsychological test battery. It was comprised of a series of 
5 standard shapes (a triangle, a diamond, a triangle overlapping a 
square, a series of lines at different angles, and a cube) that had to 
be copied  [15] , and a trail-making test in which the participant 
was asked to draw a series of lines connecting numbered circles 
 [16] . A second handwriting sample was collected as part of a lit-
eracy test (10–60 min after the first sample); the participant was 
asked to copy a standardized handwritten sentence, ‘I have a cal-
endar in my room’ onto a sheet of paper.
 Rating Handwriting Samples 
 A medical student (S.T.) was trained by a senior neurologist 
specializing in tremor disorders (E.D.L.) to rate the severity of 
tremor in the 5 shapes and the trail-making test. Tremor was rat-
ed from 0 to 2 in each of the 6 items. The ratings were: 0 (no trem-
or), 0.5 (possible tremor), 1.0 (clear tremor that was mild, equiva-
lent to a rating of 2 on an Archimedes spiral in the rating scale of 
Bain and Findley  [17] ), 1.5 (mild to moderate tremor, equivalent 
to a rating of 3–4 in Bain and Findley  [17] ), 2 (moderate or great-
er tremor, equivalent to a rating  6 5 in Bain and Findley  [17] ) 
( fig. 1 ). Based on the six rated items, a total tremor score was gen-
erated for each participant (range = 0–12). After training was 
completed, agreement between the medical student and senior 
neurologist was assessed using handwriting samples from 25 par-
ticipants, and agreement was substantial (for total tremor score, 
intraclass correlation coefficient = 0.80). The student then began 
to review the research records of each participant, rating tremor. 
During the course of these ratings, which required 3 months, ev-
ery 40th sample (i.e. 2.5% of all samples) was selected for indepen-
dent rating by the student and the senior neurologist to ensure 
that agreement remained high. For these ratings, the intraclass 
correlation coefficient = 0.71.
 ET Diagnosis 
 Bain and Findley  [17] suggested that their tremor rating  6 2 
be used to distinguish ET from enhanced physiological tremor 
because this rating corresponded with twice that of the 95th per-
centile seen in healthy controls. As noted above, their rating of 2 
is the visual equivalent to our rating of 1.0. A tremor rating of 1.0 
on each of our six rated items would result in a total tremor score 
of 6.0. To be more inclusive (i.e. accounting for the possibility that 
1 of the 6 items could have received a rating of 0.5), we considered 
those with a total tremor score of 5.5 or higher as having a pre-
liminary diagnosis of ET and these participants were selected for 
further consideration. The senior neurologist reviewed their re-
cords, rerating tremor and assigning a total tremor score. As an 
additional test, the handwritten sentence was rated by the senior 
neurologist using the published guidelines of Bain and Findley 
 [17] , with any Bain and Findley rating  6 2 being considered con-
sistent with ET. A final diagnosis of ET was assigned when the 
senior neurologist confirmed a total tremor score of 5.5 or higher 
or rated the handwritten sentence  6 2 ( fig. 2 ). Participants were 
not assigned a final diagnosis of ET if they were diagnosed with 
PD, were ever told they had PD, had used levodopa at any point in 
their lives, or if the tremor was related to another neurological 
disorder. Subsequently, 9 of the ET cases were randomly selected 
for enrollment in an epidemiological study of ET  [18] and each 
had a complete videotaped tremor examination (sustained arm 
extension, pouring, drinking, using a spoon, finger-nose-finger 
maneuver and writing); the diagnosis of ET was confirmed in 
100% of these based on published research criteria (moderate or 
greater amplitude tremor during 3 activities or a head tremor in 
the absence of PD, dystonia or another neurological disorder) 
 [18] .
 Final Sample 
 Complete data were available on 1,965 (90.4%) of 2,174 par-
ticipants. The remaining 209 participants refused the writing 
tasks due to poor eye sight or difficulty following the instructions. 
In one instance, a participant completed the drawings but not the 
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 Fig. 2. Example of handwritten sentences with 









Fig. 1. Examples of drawings with tremor ratings of 0 (A), 0.5 (B, C), 1.0 (D, E), 1.5 (F), and 2 (G, H). For each ex-
ample (A–H), the preprinted sample is on the left and hand-drawn copy by the study participant is on the right.
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written sentence; this was because tremor made writing diffi-
cult.
 Statistical Analyses 
 ! 2 tests were used to compare proportions. We calculated 
point estimates and 95% confidence intervals (95% CIs). Overall 
frequency was provided as a crude estimate and adjusted esti-
mates (2000 United States Census, age  6 65)  [19] .
 Results 
 The mean  8 SD age of the final sample of 1,965 par-
ticipants was 76.7  8 6.9 years (range = 66–102); 1,306 
(66.5%) were women. Ethnicity was 589 (30.0%) non-
Hispanic white, 642 (32.7%) non-Hispanic African-
American, 702 (35.7%) Hispanic, and 32 (1.6%) other. 
Mean education was 10.4  8 4.8 years. Forty (2.1%) of 
1,965 were diagnosed with PD or had previously been 
told they had PD or had used levodopa at any point in 
their lives.
 One-hundred-forty-two (7.2%) of 1,965 participants 
were assigned a preliminary diagnosis of ET, but 13 were 
excluded because they were diagnosed with PD or had 
been told they had PD or had used levodopa at any point 
in their lives, leaving 129 (6.6% of 1,965) participants with 
a preliminary diagnosis of ET. A final diagnosis of ET was 
assigned to 108 of 1,965 participants (crude prevalence = 
5.5%, 95% CI = 4.5–6.5%). After age adjustment to the 
2000 United States Census, the estimated prevalence in 
the United States population (age  6 65 years) was 5.0%, 
95% CI = 4.0–6.0%, and after similar adjustment for His-
panic status, prevalence was 4.9%, 95% CI = 4.0–5.9%. 
Thirty-four (31.5%) of 108 had answered ‘yes’ to the ques-
tion ‘do your arms or legs shake?’
 The prevalence of ET was similar by gender. It was 
higher in African-Americans and Hispanics than whites 
and increased with age, reaching 21.7% among the oldest 
old (age  6 95 years) ( table 1 ). The prevalence of ET is 
shown within strata defined by ethnicity and age ( ta-
ble 2 ).
 In a logistic regression analysis that included age, 
gender and ethnicity, the odds of ET (dependent vari-
able) were associated with age [odds ratio (OR) = 1.14, 
95% CI = 1.03–1.26, p = 0.01], i.e. with every 1 year 
 advance in age, the odds of ET increased by 14%) and 
Hispanic versus white ethnicity (OR = 2.19, 95% CI = 
1.03–4.64, p = 0.04) but not with female gender (OR = 
1.07, 95% CI = 0.58–1.96, p = 0.83) or African American 
versus white ethnicity (OR = 1.50, 95% CI = 0.66–3.37, 
p = 0.33).






Men 38/659 5.8 (3.9–7.5)
Women 70/1,306 5.4 (4.1–6.5)
Ethnicity
Non-Hispanic white 18/589 3.1 (1.6–4.4)
Non-Hispanic
African-American 38/642 5.9 (4.1–7.7)
Hispanic 51/702 7.3 (5.3–9.1)
Other 1/32 3.1 (0.0–8.1)
Age (10-year strata)
65–74 22/868 2.5 (1.5–3.5)
75–84 55/812 6.8 (5.0–8.4)
85–94 26/262 9.9 (6.3–13.5)
95 and older 5/23 21.7 (4.4–37.7)
95% CI is shown in parentheses. For gender, !2 = 0.14, p = 0.71.
For ethnicity, !2 = 11.55, p = 0.009. (For white vs. African-Amer-
ican, !2 = 5.80, p = 0.016; for white vs. Hispanic, !2 = 11.22, p = 
0.001; for Hispanic vs. African-American, !2 = 0.98, p = 0.32). For 
age (10-year strata), !2 = 38.78, p < 0.001.
Table 2. Prevalence of ET within strata defined by ethnicity and age
65–74 years 75–84 years 85 years and older
Non-Hispanic white 5/249 (2.0, 0.3–3.7) 10/229 (4.4, 1.7–6.9) 3/111 (2.7, 0.0–5.7)
Non-Hispanic African-American 5/270 (1.9, 0.2–3.4) 17/271 (6.3, 3.3–9.1) 16/101 (15.8, 8.0–22.0)
Hispanic 12/336 (3.6, 1.5–5.5) 27/298 (9.1, 5.8–12.3) 12/68 (17.6, 8.1–25.9)
Other 0/13 (0.0) 1/13 (7.7, 0–22.0) 0/5 (0.0)
Values are number of ET cases/number of participants. Percentages and 95% CI are shown in parentheses).
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 It is conceivable that handwriting tremor could have 
been the result of other medical comorbidities (especially, 
thyroid disease, stroke, arthritis) or tremor-producing 
medications. However, these comorbidities were no more 
common in our ET cases than in other participants. Sim-
ilarly, the current use of a variety of tremor-producing 
medications (e.g., thyroid supplements, steroids, estrogen 
replacement therapy, insulin, oral hypoglycemic agents, 
antidepressants) did not differ in ET cases versus other 
participants. These data suggest that comorbidity and 
medications were not likely to have been the cause of 
tremor.
 Discussion 
 The prevalence of ET was high (5.5%) and rose mark-
edly with age. In the oldest old, more than 1 in 5 indi-
viduals had ET. This study did not rely on a screening 
questionnaire, as was a design feature in several prior 
prevalence studies  [1, 6, 7] . In a study in Italy, the crude 
prevalence of ET was 97/4,573 (2.1%) in persons aged  6 61 
years  [6] . The low estimate was likely due to the fact that 
the initial examination was performed by general practi-
tioners rather than neurologists specializing in move-
ment disorders  [6] . A study of Arabic villagers aged  6 65 
years in Israel also reported a low crude prevalence of 
8/424 (1.9%), leading the investigators to query whether 
the prevalence might be particularly low in that ethnic 
group  [7] . Dogu et al.  [1] studied tremor in Mersin, Tur-
key. Each participant was examined by a study neurolo-
gist and the authors used the same standardized exami-
nation and diagnostic criteria as Inzelberg et al.  [7] , re-
porting a crude prevalence of ET (age  6 60 years) of 
39/622 (6.3%). Our results (prevalence in age  6 65 years 
= 5.5%) lie between those of previous studies  [1, 6, 7] , yet 
closer to those of Dogu et al.  [1] .
 Ethnic differences, if present in ET, could reflect dif-
ferences in the prevalence of susceptibility genotypes; 
they could also reflect differences in exposure to envi-
ronmental factors that have been associated with ET  [20] . 
Ethnic differences in the prevalence of ET have received 
only modest attention. Tan et al.  [12] studied the preva-
lence of ET in a community-based survey in Singapore, 
comparing Singaporean Chinese, Malays, and Indians. 
The prevalence was marginally higher in Indians than in 
Chinese (p = 0.08). No Malays with ET were identified. 
Inzelberg et al.  [7] reported a very low prevalence among 
Arabic villagers in Israel; however, there was no formal 
comparison with other ethnic groups in Israel. In a study 
in Copiah county, Mississippi, there was a nonsignificant 
trend for ET to be higher among whites than African-
Americans although it is important to note that the study 
relied on an initial screening questionnaire, which could 
have biased results toward lower prevalence among less 
educated participants  [11] . Similarly, an earlier study in 
northern Manhattan that analyzed data on 2,117 persons 
aged  6 65 years recruited in 1992 (WHICAP I), reported 
a nonsignificant trend towards a higher prevalence in 
whites than African-Americans; however, that study also 
relied on an initial screening questionnaire  [10] . By con-
trast, the current study, which did not rely on an initial 
screening questionnaire, reports a significant ethnic dif-
ference in the prevalence of ET, with the prevalence 
among whites being the lowest. Clearly, ethnic differenc-
es in ET require further study.
 As reported previously  [1, 5, 21, 22] , the prevalence of 
ET increased with age. This is one feature of the disease 
that has been used to support the notion that it is degen-
erative. Recent postmortem studies report degenerative-
type changes in the ET brain, including Purkinje cell loss 
 [23–25] . Of additional interest is that prevalence of ET 
continued to rise in the oldest age groups. Prior studies 
of ET generally have not reported separate prevalence es-
timates for persons aged 90 and older. Other than our 
study, Mancini et al.  [6] similarly reported that preva-
lence continued to rise in persons age 90 and older. There 
is a mixed literature in other late-life degenerative disor-
ders (e.g. PD), with many demonstrating a continued in-
crease with advancing age  [26] while others suggest a re-
duction in incidence or prevalence in the oldest old  [27, 
28] .
 Approximately one-half of our ET cases did not report 
tremor. Previous work in community-based studies, in 
which ET cases often have mild tremor, has similarly 
demonstrated a high proportion of cases who do not re-
port tremor (e.g., 28.3%  [10] , 31.3%  [8] , and 50.0%  [29] ).
 As noted above, in WHICAP I (1992), we estimated 
the prevalence of ET in an earlier, different sample of per-
sons living in the same neighborhoods in northern Man-
hattan  [10] . Aside from being a completely different sam-
ple from the one reported here, the earlier study used a 
different method for ascertaining ET cases (based on a 
screening questionnaire) and handwriting samples were 
not routinely analyzed as we did here. Hence, the earlier 
estimate of crude prevalence, 3.9%, was lower than that 
reported here.
 This study had limitations. First, ET was diagnosed 
based on handwriting. It is possible that we underascer-
tained cases whose tremor manifested only during tasks 
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other than writing. Thus, the results reported in this pa-
per may be a conservative estimate of prevalence. In a 
previous population-based study of ET, we observed that 
15.5% of ET cases had no tremor while drawing one spiral 
with their dominant arm  [30] . Similarly, Dogu et al.  [31] 
observed this value to be 12.4%. However, in the current 
study, we used multiple different writing tasks/samples so 
that this proportion is likely to have been far lower. Even 
if the actual prevalence were 15% higher, it would have 
been similar to our estimate (6.3% rather than 5.5%). On 
the other hand, we may also have included some cases of 
primary writing tremor  [32] ; however, this entity is rare 
 [33] (by one estimate its prevalence was 1/200th that of 
ET)  [34], and this would not have been a major source of 
misclassification. Second, we did not assess head tremor. 
However, previous ET series indicate that isolated head 
tremor cases comprise a small proportion of ET cases 
(e.g., 0.0%  [35] , 0.0%  [7] , 1.6%  [21] , 2.0%  [34] , 3.2%  [36] ) 
so that this was not likely to have been a major source of 
underestimation. Third, we could not estimate preva-
lence in younger individuals. Fourth, family history data 
were not routinely collected so that we could not assess 
ethnic differences in familial tremor. Finally, although it 
is conceivable that we failed to ascertain tremor in indi-
viduals with severe ET who could not perform the writ-
ing tasks, our data indicate that no participants fell into 
this category.
 This study had several strengths. First, it was popula-
tion-based rather than clinic-based. Second, as in rela-
tively few other studies  [1, 6, 7] , our prevalence estimate 
was based on direct evaluation of each participant rather 
than a screening questionnaire. Such screens are known 
to have low sensitivities  [21, 37] . Third, few prior studies 
have reported separate prevalence estimates for persons 
aged 90 and older  [6] ; we were able to address whether 
and to what extent the prevalence rose in the oldest old. 
Finally, with few other exceptions  [11, 12] , the Washing-
ton-Heights population is the only one in which ethnic 
differences in the prevalence of this common disorder 
have been directly assessed.
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